New treatments in pediatric brain tumors

Current Treatment Options in Neurology

Volumn 6, Issue 5, 2004, Pages 377-389

  Packer, Roger J ^a   Reddy, Alyssa ^a  

^a CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; FOLINIC ACID; GROWTH FACTOR RECEPTOR; LOMUSTINE; METHOTREXATE; PLATELET DERIVED GROWTH FACTOR; PROCARBAZINE; RECEPTOR BLOCKING AGENT; RETINOIC ACID; TEMOZOLOMIDE; TIOGUANINE; VINCRISTINE;

ANEMIA; ARTICLE; BONE MARROW SUPPRESSION; BRAIN TUMOR; CHEMOTHERAPY; CHEMOTHERAPY INDUCED EMESIS; CHILD; CLINICAL TRIAL; CONSTIPATION; DRUG RESEARCH; EPENDYMOMA; GENE TARGETING; GENE THERAPY; GLIOMA; HAIR LOSS; HEMORRHAGIC CYSTITIS; HUMAN; INFECTION; INFERTILITY; LEUKOENCEPHALOPATHY; LIVER TOXICITY; LONG TERM CARE; MEDULLOBLASTOMA; NAUSEA; NEPHROTOXICITY; NEUROBLASTOMA; NEUROECTODERM TUMOR; NEUROLOGIC DISEASE; NEURORADIOLOGY; NEUROSURGERY; NEUTROPENIA; OTOTOXICITY; PAIN; PERIPHERAL NEUROPATHY; QUALITY OF LIFE; RADIOTHERAPY; RHABDOID TUMOR; SIDE EFFECT; SURVIVAL RATE; TERATOMA; THROMBOCYTOPENIA; TREATMENT OUTCOME;

EID: 4544357947     PISSN: 10928480     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11940-996-0029-3     Document Type: Article

References (32)

1. Pomeroy SL, Tamayo P, Gaasenbeek M, et al.: Prediction of central nervous system embryonal tumour outcome based on gene expression. Nature 2002, 415:436-442.
2. MacDonald TJ, Brown KM, LeFleur B, et al.: Expression profiling of medulloblastoma: PDGFRA and the RAS/MAPK pathway as therapeutic targets for metastatic disease. Nat Gen 2001, 29:143-152.
3. Thomas PRM, Deutsch M, Kepner JL, et al.: Low-stage medulloblastoma: final analysis of trial comparing standard-dose with reduced-dose neuroaxis irradiation. J Clin Oncol 2000, 18:3004-3011.
4. Packer RJ, Goldwein J, Nicholson HS, et al.: Treatment of children with medulloblastomas with reduced-dose craniospinal radiation therapy and adjuvant chemotherapy: a children's cancer group study. J Clin Oncol 1999, 17:2127-2136.
5. Kortmann R-D, Kuhl J, Timmermann B, et al.: Postoperative neoadjuvant chemotherapy before radiotherapy as compared to immediate radiotherapy followed by maintenance chemotherapy in the treatment of medulloblastoma in childhood: results of the German prospective randomized trial HIT '91. Int J Radiat Oncol Biol Phys 2000, 46:269-279.
6. Taylor RD, Bailey CC, Robinson K, et al.: Results of a randomized study of preradiation chemotherapy versus radiotherapy alone for nonmetastatic medulloblastoma: The international Society of Paediatric Oncology/United Kingdom Children's Cancer Study Group PNET-3 Study. J Clin Oncol 2003, 21:1581-1591
7. Timmermann B, Kortmann R-D, Kuhl J, et al.: Role of radiotherapy in the treatment of supratentorial primitive neuroectodermal tumors in childhood: results of the prospective German brain tumor trials HIT 88/89 and 91. J Clin Oncol 2002, 20:842-849.
8. Packer RJ, Biegel JA, Blaney S, et al.: Atypical teratoid/ rhabdoid tumor of the central nervous system: report on workshop. J Pediatr Hematol Oncol 2002, 24:337-342.
9. Biegel JA, Kalpana G, Knudsen ES, et al.: The role if INI1 and the SWI/SNF complex in the development of rhabdoid tumors: meeting summary from the workshop on childhood atypical teratoid/rhabdoid tumors. Cancer Res 2002, 62:323-328.
10. Fouladi M, Helton K, Dalton J, et al.: Clear cell ependymoma: a clinicopathologic and radiographic analysis of 10 patients. Cancer 2003, 98:2232-2244.
11. Strother D, Ashley D, Kellie SJ, et al.: Feasibility of four consecutive high-dose chemotherapy cycles with stem-cell rescue for patients with newly diagnosed medulloblastoma or supratentorial primitive neuroectodermal tumor after craniospinal radiotherapy: results of a collaborative study. J Clin Oncol 2001, 19:2696-2704.
12. Zeltzer PM, Boyett JM, Finlay JL, et al.: Metastasis stage, adjuvant treatment, and residual tumor are prognostic factors for medulloblastoma in children: conclusions from the Children's Cancer Group 921 randomized phase III study. J Clin Oncol 1999, 17:832-845.
13. Pollack IF, Polinko P, Albright AL, et al.: Mutism and pseudobulbar symptoms after resection of posterior fossa tumors in children: incidence and pathophysiology. Neurosurgery 1995, 37:885-893.
14. Wolden SL, Dunkel IJ, Souweidane MM, et al.: Patterns of failure using a conformal radiation therapy tumor bed boost for medulloblastoma. J Clin Oncol 2003, 21:3079-3083.
15. Ris MD, Packer R, Goldwein J, et al.: Intellectual outcome after reduced-dose radiation therapy plus adjuvant chemotherapy for medulloblastoma: a children's cancer group study, J Clin Oncol 2001, 19:3470-3576.
16. Palmer SL, Goloubeva O, Reddick WE, et al.: Patterns of intellectual development among survivors of pediatric medulloblastoma: a longitudinal analysis. J Clin Oncol 2001, 19:2302-2308.
17. Packer RJ, Boyett JM, Janss AJ: Growth hormone replacement therapy in children with medulloblastoma: use and effect on tumor control. J Clin Oncol 2001, 19:480-487.
18. Gururangan S, McLaughlin C, Quinn J, et al.: High-dose chemotherapy with autologous stem-cell rescue in children and adults with newly diagnosed pineoblastomas. J Clin Oncol 2003, 21:2187-2191.
19. Marec-Berard P, Jouvet A, Thiesse P, et al.: Supratentorial embryonal tumors in children under 5 years of age: an S FOP study of treatment with postoperative chemotherapy alone. Med Pediatr Oncol 2002, 38:83-90.
20. Stafford SL, Pollock BE, Foote RL, et al.: Stereotactic radiosurgery for recurrent ependymoma. Cancer 2000, 88:870-875.
21. Gropman AL, Packer RJ, Nicholson HS, et al.: Treatment of diencephalic syndrome with chemotherapy: growth, tumor response, and long term control. Cancer 1998, 83:166-172.
22. Packer RJ, Ater J, Allen J, et al.: Treatment utilizing carboplatin and vincristine for children with newly diagnosed progressive low-grade gliomas. J Neurosurg 1997, 56:747-754.
23. Arita K, Kurisus K, Sugiyama K, et al.: Long-term results of conventional treatment of diencephalic pilocytic astrocytoma in infants. Childs Nerv Syst 2003, 19:145-151.
24. Boethius J, Ulfarsson E, Rahn T, Lippittz B: Gamma knife radiosurgery for pilocytic astrocytomas. J Neurosurg 2002, 97:677-680.
25. Hadjipanayis CG, Kondziolka D, Gardner P, et al.: Stereotactic radiosurgery for pilocytic astrocytomas when multimodal therapy is necessary. J Neurosurg 2002, 97:56-64.
26. Pompili A, Caperle M, Pace A, et al.: Quality-of-life assessment in patients who had been surgically treated for cerebellar pilocytic Astrocytoma in childhood. J Neurosurg 2002, 96:229-234.
27. Wisoff JH, Boyett JM, Berger MS, et al.: Current neurosurgical management and the impact of the extent of resection in the treatment of malignant gliomas of childhood: a report of the Children's Cancer Group Trial No. CCG-945. J Neurosurg 1998, 89:52-59.
28. Jakacki RI, Siffert J, Jamison C, Velasquez L, Allen JC: Dose-intensive, time-compressed procarbazine, CCNU, vincristine (PCV) with peripheral blood stem cell support and concurrent radiation in patients with newly diagnosed high-grade gliomas. J Neurooncol 1999, 44:77-83.
29. Huncharek M, Wheeler L, McGarry R, Geschwind JF: Chemotherapy response rates in recurrent/progressive pediatric glioma; results of a systematic review. Anticancer Res 1999, 19:3569-3574.
30. Cohen KJ, Aronson LJ, Siffert J, et al.: A phase I trial of low-dose temozolomide given concurrently with radiation therapy in children and adolescents with brain tumors. Neurooncol 2002, 3:370.
31. Hodgson DC, Goumnerova LC, Loeffler JS, et al.: Radiosurgery in the management of pediatric brain tumors. Int J Radiat Oncol Biol Phys 2001, 50:929-935.
32. Markert JM, Medlock MD, Rabkin SD, et al.: Conditionally replicating herpes simplex virus mutant, G207 for the treatment of malignant glioma: results of a phase I trial. Gene Ther 2000 7:867-874.